These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Prophylactic Supplementation with Lactobacillus Reuteri or Its Metabolite GABA Protects Against Acute Ischemic Cardiac Injury. Wang J; Zhang H; Yuan H; Chen S; Yu Y; Zhang X; Gao Z; Du H; Li W; Wang Y; Xia P; Wang J; Song M Adv Sci (Weinh); 2024 May; 11(18):e2307233. PubMed ID: 38487926 [TBL] [Abstract][Full Text] [Related]
3. Lactobacillus reuteri A9 and Lactobacillus mucosae A13 isolated from Chinese superlongevity people modulate lipid metabolism in a hypercholesterolemia rat model. Jiang J; Feng N; Zhang C; Liu F; Zhao J; Zhang H; Zhai Q; Chen W FEMS Microbiol Lett; 2019 Dec; 366(24):. PubMed ID: 31855230 [TBL] [Abstract][Full Text] [Related]
4. Effects of hypercholesterolemia on myocardial ischemia-reperfusion injury in LDL receptor-deficient mice. Girod WG; Jones SP; Sieber N; Aw TY; Lefer DJ Arterioscler Thromb Vasc Biol; 1999 Nov; 19(11):2776-81. PubMed ID: 10559025 [TBL] [Abstract][Full Text] [Related]
5. Lactobacillus reuteri mitigates hepatic ischemia/reperfusion injury by modulating gut microbiota and metabolism through the Nrf2/HO-1 signaling. Zhang L; Gong X; Tan J; Zhang R; Li M; Liu C; Wu C; Li X Biol Direct; 2024 Mar; 19(1):23. PubMed ID: 38500127 [TBL] [Abstract][Full Text] [Related]
6. FXR Signaling-Mediated Bile Acid Metabolism Is Critical for Alleviation of Cholesterol Gallstones by Ye X; Huang D; Dong Z; Wang X; Ning M; Xia J; Shen S; Wu S; Shi Y; Wang J; Wan X Microbiol Spectr; 2022 Oct; 10(5):e0051822. PubMed ID: 36036629 [TBL] [Abstract][Full Text] [Related]
7. Lactobacillus reuteri F-9-35 Prevents DSS-Induced Colitis by Inhibiting Proinflammatory Gene Expression and Restoring the Gut Microbiota in Mice. Sun MC; Zhang FC; Yin X; Cheng BJ; Zhao CH; Wang YL; Zhang ZZ; Hao HW; Zhang TH; Ye HQ J Food Sci; 2018 Oct; 83(10):2645-2652. PubMed ID: 30216448 [TBL] [Abstract][Full Text] [Related]
8. Cholesterol-lowering efficacy of a microencapsulated bile salt hydrolase-active Lactobacillus reuteri NCIMB 30242 yoghurt formulation in hypercholesterolaemic adults. Jones ML; Martoni CJ; Parent M; Prakash S Br J Nutr; 2012 May; 107(10):1505-13. PubMed ID: 22067612 [TBL] [Abstract][Full Text] [Related]
9. Oral supplementation with probiotic L. reuteri NCIMB 30242 increases mean circulating 25-hydroxyvitamin D: a post hoc analysis of a randomized controlled trial. Jones ML; Martoni CJ; Prakash S J Clin Endocrinol Metab; 2013 Jul; 98(7):2944-51. PubMed ID: 23609838 [TBL] [Abstract][Full Text] [Related]
10. Effect of Antiobiotic-Induced Disbiosis and Its Correction with Probiotics on Myocardial Tolerance to Ischemia-Reperfusion Injury in SPF Rats. Borshchev YY; Sinitsa AV; Zakharchenko MM; Borshchev VY; Burovenko IY; Galagudza MM Bull Exp Biol Med; 2019 Feb; 166(4):440-443. PubMed ID: 30788733 [TBL] [Abstract][Full Text] [Related]
11. Supplementary heat-killed Lactobacillus reuteri GMNL-263 ameliorates hyperlipidaemic and cardiac apoptosis in high-fat diet-fed hamsters to maintain cardiovascular function. Ting WJ; Kuo WW; Kuo CH; Yeh YL; Shen CY; Chen YH; Ho TJ; Viswanadha VP; Chen YH; Huang CY Br J Nutr; 2015 Sep; 114(5):706-12. PubMed ID: 26234728 [TBL] [Abstract][Full Text] [Related]
12. Hypocholesterolemic Effects of Probiotic Mixture on Diet-Induced Hypercholesterolemic Rats. Kim SJ; Park SH; Sin HS; Jang SH; Lee SW; Kim SY; Kwon B; Yu KY; Kim SY; Yang DK Nutrients; 2017 Mar; 9(3):. PubMed ID: 28300786 [TBL] [Abstract][Full Text] [Related]
13. The beneficial effects of Lactobacillus reuteri ADR-1 or ADR-3 consumption on type 2 diabetes mellitus: a randomized, double-blinded, placebo-controlled trial. Hsieh MC; Tsai WH; Jheng YP; Su SL; Wang SY; Lin CC; Chen YH; Chang WW Sci Rep; 2018 Nov; 8(1):16791. PubMed ID: 30429496 [TBL] [Abstract][Full Text] [Related]
14. Hypocholesterolemic effects of Lactobacillus reuteri LR6 in rats fed on high-cholesterol diet. Singh TP; Malik RK; Katkamwar SG; Kaur G Int J Food Sci Nutr; 2015 Feb; 66(1):71-5. PubMed ID: 25265203 [TBL] [Abstract][Full Text] [Related]
15. Liu Y; Tian X; He B; Hoang TK; Taylor CM; Blanchard E; Freeborn J; Park S; Luo M; Couturier J; Tran DQ; Roos S; Wu G; Rhoads JM Am J Physiol Gastrointest Liver Physiol; 2019 Dec; 317(6):G824-G838. PubMed ID: 31482733 [TBL] [Abstract][Full Text] [Related]
16. Limosilactobacillus reuteri consumption significantly reduces the total cholesterol concentration without affecting other cardiovascular disease risk factors in adults: A systematic review and meta-analysis. Liu J; Zhu R; Song J; Sohaib M; Wang S; Mao J; Qi J; Xiong X; Zhou W; Guo L Nutr Res; 2023 Sep; 117():1-14. PubMed ID: 37419064 [TBL] [Abstract][Full Text] [Related]
17. Characterization of the anti-inflammatory Lactobacillus reuteri BM36301 and its probiotic benefits on aged mice. Lee J; Yang W; Hostetler A; Schultz N; Suckow MA; Stewart KL; Kim DD; Kim HS BMC Microbiol; 2016 Apr; 16():69. PubMed ID: 27095067 [TBL] [Abstract][Full Text] [Related]
18. Effect of Lactobacillus acidophilus NS1 on plasma cholesterol levels in diet-induced obese mice. Song M; Park S; Lee H; Min B; Jung S; Park S; Kim E; Oh S J Dairy Sci; 2015 Mar; 98(3):1492-501. PubMed ID: 25468703 [TBL] [Abstract][Full Text] [Related]
19. [Influence of Lactobacillus reuteri SL001 on intestinal microbiota in AD model mice and C57BL/6 mice]. Liu M; Hu R; Guo Y; Sun W; Li J; Fan M; Wang Y; Du H; Tang Z; Chai C Sheng Wu Gong Cheng Xue Bao; 2020 Sep; 36(9):1887-1898. PubMed ID: 33164464 [TBL] [Abstract][Full Text] [Related]
20. Effect of Limosilactobacillus reuteri ZJF036 on Growth Performance and Gut Microbiota in Juvenile Beagle Dogs. Zhao D; Zhang R; Wang J; Zhang X; Liu K; Zhang H; Liu H Curr Microbiol; 2023 Mar; 80(5):155. PubMed ID: 36995478 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]